Who are Astrocyte Pharmaceuticals's investors?

Astrocyte Pharmaceuticals's investors include Boston Harbor Angels, UT Horizon Fund.

How much funding has Astrocyte Pharmaceuticals raised?

Astrocyte Pharmaceuticals has disclosed $12.8M raised across 3 rounds.

Where is Astrocyte Pharmaceuticals headquartered?

Astrocyte Pharmaceuticals is headquartered in Groton, US.

Astrocyte Pharmaceuticals

Groton, US · Delaware corporation · 2 known investors

Cloudflare provides web performance and security infrastructure solutions, helping websites optimize speed and protect against threats and malicious traffic.

Cloud Computing Cybersecurity Healthtech

Founders & leadership

James D. LechleiterNamed on SEC filing

William KorinekNamed on SEC filing

Jeffrey L. IvesNamed on SEC filing

Investors · 2

Boston Harbor AngelsBoston · $250K – $1.5M

UT Horizon FundAustin

Reported raises · per SEC filings

Form D private placements

$12.8M disclosed across 3 rounds · 2017–2022

▶$2.8MraisedOct 2022 · 48 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

William S. KorinekExecutive Officer, Director
Christine GallagherDirector
Jeffrey IvesDirector
Jeffrey ArnoldDirector
Jackson StreeterDirector

Offering amount: $5M
Amount sold: $2.8M
First sale: Oct 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$7.5MraisedDec 2020 · 70 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Jeffrey ArnoldDirector
Jeffrey IvesDirector
William KorinekExecutive Officer, Director

Offering amount: $8.7M
Amount sold: $7.5M
First sale: Nov 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.4MraisedJul 2017 · 46 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

James D. LechleiterDirector
William KorinekExecutive Officer, Director
Jeffrey L. IvesDirector

Offering amount: $2.4M
Amount sold: $2.4M
First sale: Mar 2017
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Intechopen61 shared keywordsIntechOpen is an open-access academic publisher that publishes peer-reviewed scientific works and books across diverse fields. The platform provides researchers with tools for publishing, wider readership, and increased citation visibility.

Companies competing with Astrocyte Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2018	$3M
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2018	$297.9K
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2015	$671.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Astrocyte Pharmaceuticals do?: Cloudflare provides web performance and security infrastructure solutions, helping websites optimize speed and protect against threats and malicious traffic.
Who are Astrocyte Pharmaceuticals's investors?: Astrocyte Pharmaceuticals's investors include Boston Harbor Angels, UT Horizon Fund.
How much funding has Astrocyte Pharmaceuticals raised?: Astrocyte Pharmaceuticals has disclosed $12.8M raised across 3 rounds.
Where is Astrocyte Pharmaceuticals headquartered?: Astrocyte Pharmaceuticals is headquartered in Groton, US.